Author:
Buchynskyy Andriy,Gillespie J. Robert,Hulverson Matthew A.,McQueen Joshua,Creason Sharon A.,Ranade Ranae M.,Duster Nicole A.,Gelb Michael H.,Buckner Frederick S.
Funder
National Institutes of Health
Subject
Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry
Reference20 articles.
1. Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, noninferiority trial;Priotto;Lancet,2009
2. Equivalence trial of Melarsoprol and Nifurtimox monotherapy and combination therapy for the treatment of Second-Stage Trypanosoma brucei gambiense Sleeping Sickness;Bisser;J Infect Dis,2007
3. New Oral Drug Candidate for African Sleeping Sickness; DNDi press release [Geneva, Switzerland and Kinshasa, Democratic Republic of the Congo – 6 December 2012]. http://www.dndi.org/media-centre/press-releases/354-media-centre/pressreleases/1505-new-oral-drug-candidate-hat.html.
4. Pivotal Clinical Trial to Begin for First Oral Drug Candidate Specifically Developed for Sleeping Sickness; DNDi press release [Basel, Switzerland – 8 September 2015]. http://www.dndi.org/2015/media-centre/press-releases/pr-scyx-7158/.
5. Drugs for bad bugs: confronting the challenges of antibacterial discovery;Payne;Nat Rev Drug Discov,2007
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献